OA|E-mail|Chinese TEL:400-0572-666
HOME > About Us > Company Profile
Company Profile


In May 1994, Conba Group, with the main member of Zhejiang Conba Pharmaceutical Co., Ltd., was established in Hangzhou. Its main scope of business includes investment and industrial management and the industries involved cover many fields. It has now formed an industrial system taking medicine industry as the main  usiness while biological agriculture, health food and beverage, health preservation and real estate as the auxiliary industries. As of early 2013, the group’s assets has been close to 8 billion and sales volume exceeds 7.3 billion; it ranked top forty in national pharmaceutical industry and top ten in national Chinese medicine industry.It’s also a leading backbone enterprise in Zhejiang industry, Zhejiang largest Chinese medicine enterprise and in Zhejiang top 100 private enterprises.


Zhejiang Conba Pharmaceutical Co., Ltd. (founded in 1969, listed in 2004, stock code 600572) is a holding subsidiary and main member enterprise of Conba Group Co. Ltd. It is a listed pharmaceutical enterprise integrating herbs planting and pharmaceutical R&D, production and sales. The company was previously known as “Lanxi Yunshan Pharmaceutical Factory” founded in 1969 and was renamed “Zhejiang Conba Pharmaceutical Co., Ltd.” in October 1999. The company was registered in Lanxi,


Zhejiang, with head office set in Hangzhou, Zhejiang. It owns advanced and standard pharmaceutical production bases in Hangzhou, Lanxi, Jinhua as well as Jiangxi, Yunnan, Inner Mongolia and Sichuan, etc., and has built domestic largest modern herbal medicine manufacturing base, Conba Herbal Medicine Industrial Park, in Lanxi. The company owns a dozen of wholly owned and holding subsidiaries of considerable size and strength including Zhejiang Conba Chinese Medicine Co., Ltd.,


Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd., Yunnan Xitao Green Pharmaceutical Co., Ltd., Hangzhou Conba Pharmaceutical Co., Ltd., Jiangxi Herbi-sky Co., Ltd., Zhejiang Conba Pharmaceutical R&D Co., Ltd., Zhejiang Conba Pharmaceutical Sales Co., Ltd., Shanghai Conba Pharmaceutical Sales Co., Ltd., Yunnan Conba Herbal Medicine Co., Ltd. and Inner Mongolia Conba Pharmaceutical Sales Co., Ltd., etc.
Conba always adheres to building its own core competitiveness. R&D and brand have always been two advantages of Conba.
First of all, Conba has multiple new drug R&D technology platforms and an elite technical team. It has established long-term strategic partnership and strategic alliance relationship with domestic and foreign well-known research institutions, colleges and universities. In the fields of drug R&D as well as plant extraction and separation, structure modification and new drug release system application, etc., it develops new drugs with independent intellectual property right, and in the links of herbs planting, active pharmaceutical ingredients and plant extraction, new drug R&D, preparation production and marketing, etc., it has built a standard and efficient industrial system and become the only enterprise integrating national technology center, national post-doctoral research workstation, academicians workstation, national innovative enterprise and Zhejiang key enterprise research institute in traditional Chinese medicine industry in Zhejiang.
Secondly, Conba attaches particular importance to product brand and enterprise brand cultivation and protection, so it has built brands familiar to and recognized by consumers in several fields including urinary system and cardiovascular system, etc. Now, the company has become one of the enterprises owning the most famous trademarks and brand products, among which “Conba”, “Prostate Plus”, "Zhenshiming" are identified as famous trademark of China, while “Prostate Plus”, as the company’s leading herbal medicinal product, has become the first brand in domestic Chinese herbal medicines treating BPH; “Tianbaoning” is China's first modern herbal medicine preparation meeting international quality standards. In addition, “Alocin”, “Xitao”, “Yuanbang”, “Baby” and “Omeprazole”, etc., have considerable brand awareness in their respective fields and set up considerable brand advantages in similar competitive products.
While committed to enterprise development, Conba has always been committed to the assumption of social responsibilities. As of April 2013, Conba has totally donated RMB 180 million of money and things for all kinds of public welfares and won many charity awards including "China Charity Award", the highest government award in China’s charity filed, as well as "excellent enterprise of social responsibility" jointly issued by CAEFI and China Charity Federation, etc., "Zhejiang Charity Award" issued by Zhejiang Provincial Government, “Award for Love” issued by Zhejiang Foundation for Disabled Persons, “Zhejiang Provincial Red Cross Humanitarian Award" Gold Award issued by Zhejiang Provincial Red Cross, etc., and all of these honors have witnessed Conba’s heart of responsibility and love.
Looking into the future, the company will still adhere to the corporate tenet "set world intellect, create grand cause, for human health, offer sincere love”, shoulder the corporate mission “devote to plant technology, present green essence, serve healthy living”, strive to exploit company’s overall strength and brand advantage, be committed to serving consumer health as always and strive to build Conba as a world famous enterprise in the field of herbal medicines!